Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

( MENAFN - Swissinfo) Swiss medicines regulator Swissmedic has taken legal action against media houses in Switzerland for ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...